IAPAC-Lancet HIV Commission on the future of urban HIV responses

José M Zuniga¹, Corey Prachniak², Nicoletta Policek³, Nombulelo Magula⁴, Anisha Gandhi⁵, Jane Anderson⁶, Dázon Dixon Diallo⁷, Viviane Dias Lima⁸, Sindhu Ravishankar⁹, Shrikala Acharya¹⁰, Angeli Achrekar¹¹, Monsurat Adeleke¹², Élodie Aïna¹³, Solange Baptiste¹⁴, Geoffrey Barrow¹⁵, Josip Begovac¹⁶, Elizabeth Bukusi¹⁷, Amanda Castel¹⁸, Erika Castellanos¹⁹, Jorge Cestou²⁰, Gertrude Chirambo²¹, Jeffrey Crowley²², Nikos Dedes²³, Lucica Ditiu²⁴, Meg Doherty²⁵, Chris Duncombe²⁶, Adriana Durán²⁷, Donna Futterman²⁸, Shannon Hader²⁹, Chyrol Kounkeu³⁰, Fran Lawless³¹, Jeffrey V Lazarus³², Sabine Lex³³, Carlos Lobos³⁴, Kenneth Mayer³⁵, Maria Mejia³⁶, H Rodrigo Moheno³⁷, Antonella d'Arminio Monforte³⁸, Mónica Morán-Arribas³⁹, Daniel Nagel⁴⁰, Robert Ndugwa⁴¹, Carol Ngunu⁴², Midnight Poonkasetwattana⁴³, Maria Prins⁴⁴, Amara Quesada⁴⁵, Olga Rudnieva⁴⁶, Simon Ruth⁴⁷, Jorge Saavedra⁴⁸, Lance Toma⁴⁹, Lucy Wanjiku Njenga⁵⁰, Brian Williams⁵¹

Affiliations

¹ International Association of Providers of AIDS Care, Washington, DC, USA; Fast-Track Cities Institute, Washington, DC, USA. Electronic address: jzuniga@iapac.org.
² CenterLink, Boston, MA, USA.
³ European AIDS Treatment Group, Brussels, Belgium.
⁴ University of KwaZulu-Natal, Durban, South Africa.
⁵ New York City Department of Health and Mental Hygiene, New York, NY, USA.
⁶ Homerton University, London, UK.
⁷ SisterLove, Atlanta, GA, USA.
⁸ University of British Columbia, Vancouver, BC, Canada.
⁹ Fast-Track Cities Institute, Washington, DC, USA.
¹⁰ Mumbai District AIDS Control Society, Mumbai, India.
¹¹ Joint UN Programme on HIV/AIDS, Geneva, Switzerland.
¹² Lagos State AIDS Control Agency, Lagos, Nigeria.
¹³ Paris Sans Sida, Paris, France.
¹⁴ International Treatment Preparedness Coalition, Johannesburg, South Africa.
¹⁵ University of the West Indies, Kingston, Jamaica.
¹⁶ University of Zagreb, Zagreb, Croatia.
¹⁷ Kenya Medical Research Institute, Nairobi, Kenya; University of Nairobi, Nairobi, Kenya.
¹⁸ George Washington University, Washington, DC, USA.
¹⁹ Global Action for Trans Equality, New York, NY, USA.
²⁰ Chicago Department of Public Health, Chicago, IL, USA.
²¹ Blantyre City Council, Blantyre, Malawi.
²² Georgetown University, Washington, DC, USA.
²³ Positive Voice, Greece, Athens.
²⁴ Stop TB Partnership, Geneva, Switzerland.
²⁵ World Health Organization, Geneva, Switzerland.
²⁶ International Association of Providers of AIDS Care, Washington, DC, USA.
²⁷ Ministry of Health, City of Buenos Aires, Buenos Aires, Argentina.
²⁸ Montefiore University, New York, NY, USA.
²⁹ American University, Washington, DC, USA.
³⁰ Cameroonian Association for the Development and Empowerment of Vulnerable People, Yaoundé, Cameroon.
³¹ Mayor's Office of Health Policy, New Orleans, LA, USA.
³² University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Policy, New York, NY, USA.
³³ Aidshilfe Wien, Vienna, Austria.
³⁴ Chile Positivo, Metropolitana, Chile.
³⁵ Fenway Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
³⁶ The Well Project, Miami, FL, USA.
³⁷ Fundación México Vivo, Mexico City, Mexico.
³⁸ University of Milan, Milan, Italy.
³⁹ General Directorate of Public Health, Region of Madrid, Madrid, Spain.
⁴⁰ FAQ Health, Hamburg, Germany.
⁴¹ UN Human Settlements Programme, Nairobi, Kenya.
⁴² Nairobi City County Department of Health, Nairobi, Kenya.
⁴³ APCOM Foundation, Bangkok, Thailand.
⁴⁴ Academic Medical Center, Amsterdam, Netherlands.
⁴⁵ Action for Health Initiatives, Quezon City, Philippines.
⁴⁶ Superhumans Center, Kyiv, Ukraine.
⁴⁷ Thorne Harbour Health, Melbourne, VIC, Australia.
⁴⁸ AIDS Healthcare Foundation, Miami, FL, USA.
⁴⁹ San Francisco Community Health Center, San Francisco, CA, USA.
⁵⁰ Young Positive Women Voices, Nairobi, Kenya.
⁵¹ SACEMA, Geneva, Switzerland.

PMID: 39043198
DOI: 10.1016/S2352-3018(24)00124-3

Review

IAPAC-Lancet HIV Commission on the future of urban HIV responses

José M Zuniga et al. Lancet HIV. 2024 Sep.

. 2024 Sep;11(9):e607-e648.

doi: 10.1016/S2352-3018(24)00124-3. Epub 2024 Jul 20.

Authors

Affiliations

¹ International Association of Providers of AIDS Care, Washington, DC, USA; Fast-Track Cities Institute, Washington, DC, USA. Electronic address: jzuniga@iapac.org.
² CenterLink, Boston, MA, USA.
³ European AIDS Treatment Group, Brussels, Belgium.
⁴ University of KwaZulu-Natal, Durban, South Africa.
⁵ New York City Department of Health and Mental Hygiene, New York, NY, USA.
⁶ Homerton University, London, UK.
⁷ SisterLove, Atlanta, GA, USA.
⁸ University of British Columbia, Vancouver, BC, Canada.
⁹ Fast-Track Cities Institute, Washington, DC, USA.
¹⁰ Mumbai District AIDS Control Society, Mumbai, India.
¹¹ Joint UN Programme on HIV/AIDS, Geneva, Switzerland.
¹² Lagos State AIDS Control Agency, Lagos, Nigeria.
¹³ Paris Sans Sida, Paris, France.
¹⁴ International Treatment Preparedness Coalition, Johannesburg, South Africa.
¹⁵ University of the West Indies, Kingston, Jamaica.
¹⁶ University of Zagreb, Zagreb, Croatia.
¹⁷ Kenya Medical Research Institute, Nairobi, Kenya; University of Nairobi, Nairobi, Kenya.
¹⁸ George Washington University, Washington, DC, USA.
¹⁹ Global Action for Trans Equality, New York, NY, USA.
²⁰ Chicago Department of Public Health, Chicago, IL, USA.
²¹ Blantyre City Council, Blantyre, Malawi.
²² Georgetown University, Washington, DC, USA.
²³ Positive Voice, Greece, Athens.
²⁴ Stop TB Partnership, Geneva, Switzerland.
²⁵ World Health Organization, Geneva, Switzerland.
²⁶ International Association of Providers of AIDS Care, Washington, DC, USA.
²⁷ Ministry of Health, City of Buenos Aires, Buenos Aires, Argentina.
²⁸ Montefiore University, New York, NY, USA.
²⁹ American University, Washington, DC, USA.
³⁰ Cameroonian Association for the Development and Empowerment of Vulnerable People, Yaoundé, Cameroon.
³¹ Mayor's Office of Health Policy, New Orleans, LA, USA.
³² University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Policy, New York, NY, USA.
³³ Aidshilfe Wien, Vienna, Austria.
³⁴ Chile Positivo, Metropolitana, Chile.
³⁵ Fenway Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
³⁶ The Well Project, Miami, FL, USA.
³⁷ Fundación México Vivo, Mexico City, Mexico.
³⁸ University of Milan, Milan, Italy.
³⁹ General Directorate of Public Health, Region of Madrid, Madrid, Spain.
⁴⁰ FAQ Health, Hamburg, Germany.
⁴¹ UN Human Settlements Programme, Nairobi, Kenya.
⁴² Nairobi City County Department of Health, Nairobi, Kenya.
⁴³ APCOM Foundation, Bangkok, Thailand.
⁴⁴ Academic Medical Center, Amsterdam, Netherlands.
⁴⁵ Action for Health Initiatives, Quezon City, Philippines.
⁴⁶ Superhumans Center, Kyiv, Ukraine.
⁴⁷ Thorne Harbour Health, Melbourne, VIC, Australia.
⁴⁸ AIDS Healthcare Foundation, Miami, FL, USA.
⁴⁹ San Francisco Community Health Center, San Francisco, CA, USA.
⁵⁰ Young Positive Women Voices, Nairobi, Kenya.
⁵¹ SACEMA, Geneva, Switzerland.

PMID: 39043198
DOI: 10.1016/S2352-3018(24)00124-3

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests JMZ has received consulting fees from Gilead Sciences and Merck & Co. JA has received consulting fees from Gilead Sciences; honoraria from Gilead Sciences and ViiV Healthcare; travel support from Gilead Sciences and ViiV Healthcare; book royalties from Elsevier Royalties; and has served on a Data Safety and Monitoring Board for the RIO HIV Trial. DDD has received consulting fees from Gilead Sciences and honoraria from Gilead Sciences and ViiV Healthcare. VDL has received research grants from the Canadian Foundation for AIDS Research and Canadian Institutes of Health Research and an honorarium from ViiV Healthcare. AC has received a research grant from Gilead Sciences. ND has received an honorarium from ViiV Healthcare. CD has received consulting fees from WHO. SH has received consulting fees from the BCG Boston Consulting Group. JVL has received consulting fees from Echosens, GlaxoSmithKline, Novo Nordisk, NovoVax, and Pfizer; honoraria from AbbVie, Echosens, Gilead Sciences, Janssen Therapeutics, Moderna, Merck Sharp & Dohme, Novo Nordisk, Pfizer; and has served on a Data Safety and Monitoring Board for the QuickStart Study. KM has received research grants and consulting fees from Gilead Sciences, Merck & Co, and ViiV Healthcare. MM has received consulting fees from Janssen Therapeutics. SRa has received an honorarium from the AIDS Healthcare Foundation. All other authors declare no competing interests.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

IAPAC-Lancet HIV Commission on the future of urban HIV responses

Affiliations

IAPAC-Lancet HIV Commission on the future of urban HIV responses

Authors

Affiliations

Conflict of interest statement

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical